IFIT1 antibody (AA 100-148)
-
- Target See all IFIT1 Antibodies
- IFIT1 (Interferon-Induced Protein with Tetratricopeptide Repeats 1 (IFIT1))
-
Binding Specificity
- AA 100-148
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This IFIT1 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- Human IFIT1 / ISG56
- Purification
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa100-148 of human IFIT1 (D3DR31, NP_001257859). Percent identity by BLAST analysis: Human, Chimpanzee (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product IFIT1 Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled water
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS
- Storage
- 4 °C,-20 °C
- Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- IFIT1 (Interferon-Induced Protein with Tetratricopeptide Repeats 1 (IFIT1))
- Alternative Name
- IFIT1 / ISG56 (IFIT1 Products)
- Synonyms
- C56 antibody, G10P1 antibody, IFI-56 antibody, IFI-56K antibody, IFI56 antibody, IFIT-1 antibody, IFNAI1 antibody, ISG56 antibody, P56 antibody, RNM561 antibody, Ifi56 antibody, Garg16 antibody, DKFZp469C2331 antibody, interferon induced protein with tetratricopeptide repeats 1 antibody, interferon-induced protein with tetratricopeptide repeats 1 antibody, IFIT1 antibody, Ifit1 antibody, LOC488947 antibody, ifit1 antibody, LOC100058990 antibody, LOC100139670 antibody, LOC100475782 antibody
- Background
-
Name/Gene ID: IFIT1
Synonyms: IFIT1, C56, G10P1, GARG-16, IFI-56K, IFIT-1, Interferon-inducible mRNA 561, IFI-56, IFI56, IFNAI1, ISG56, RNM561, p56 - Gene ID
- 3434
- NCBI Accession
- NP_001257859
- Pathways
- Hepatitis C
-